Ultra Nasdaq Biotechnology Proshares (BIB) 92.15

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra Nasdaq Biotechnology Proshares (BIB) 92.15 $BIB

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 4.54% Gain
Comtex SmarTrend(R) - Tue Jul 14, 5:10PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $95.13 to a high of $99.84. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $95.56 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 92.15 (-2.11)

ProShares Ultra Nasdaq Biotechnology ETF Rises 1.36% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jul 06, 5:38PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $88.72 to a high of $93.56. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $93.18 on volume of 469,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 92.15 (-2.11)

10-Minute Guide to 10 Most Popular Leveraged ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jun 23, 9:00AM CDT
Here a handy guide to the 10 most popular leveraged ETFs for short-term investors seeking to ride out the bull run.
UYG: 77.15 (-1.27), QLD: 77.17 (-1.35), UPRO: 66.91 (-1.22), UCO: 27.78 (-1.38), BIB: 92.15 (-2.11), SSO: 64.92 (-0.76), UWTI: 1.53 (-0.11), NUGT: 3.33 (-0.41), FAS: 33.24 (-0.81), TQQQ: 114.93 (-3.03)

Two more triple-levered biotech ETFs launch
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 8:22AM CDT

BBP: 35.48 (-0.35), PBE: 58.52 (-0.54), BBC: 36.18 (-0.67), SBIO: 37.62 (-0.59), BIS: 27.60 (+0.54), HQL: 28.05 (-1.89), FBT: 123.85 (-1.42), BIB: 92.15 (-2.11), XBI: 251.78 (-3.60), BBH: 136.01 (-0.69), IBB: 373.58 (-4.00), LABU: 46.23 (-2.40), LABD: 30.37 (+1.20)

ProShares Ultra Nasdaq Biotechnology ETF Falls 2.35% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 09, 5:14PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $85.40 to a high of $88.48. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $85.73 on volume of 729,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 92.15 (-2.11)

Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Jun 09, 11:08AM CDT
A quick discussion of the ways investors can play the biotechnology sector with leverage.
BIS: 27.60 (+0.54), BIB: 92.15 (-2.11), LABU: 46.23 (-2.40), LABD: 30.37 (+1.20)

BUYINS.NET: PMC, ATHN, QNST, MLPI, PRI, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jun 08, 12:08PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of PharMerica Corp (NYSEMC), Athenahealth Inc (NASDAQ:ATHN), Quinstreet Inc (NASDAQ:QNST), E-TRACS ALERIAN INFRASTR (NYSE:MLPI), Primerica Inc (NYSERI), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
PRI: 43.99 (-0.39), PMC: 34.05 (-0.21), BIB: 92.15 (-2.11), MLPI: 33.21 (+0.34), QNST: 6.03 (-0.15), ATHN: 136.68 (+7.71)

BUYINS.NET: BIB, LYB, DPS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri May 08, 7:17AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), LyondellBasell Industries NV (NYSE:LYB), Dr Pepper Snapple Group Inc (NYSEPS) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DPS: 77.64 (-0.28), LYB: 89.85 (-0.52), BIB: 92.15 (-2.11)

Hidden Gems In This Market Cycle's Leading Theme
Cam Hui, CFA - Seeking Alpha - Fri May 08, 5:18AM CDT
Philosophical Economics wrote a terrific post yesterday about how the "Winner take all" economy is affecting companies and the competitive environment. He observed that net margins have been elevated in the last few years. Generally, when...
BIS: 27.60 (+0.54), BIB: 92.15 (-2.11), IBB: 373.58 (-4.00)

FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT

ABT: 50.69 (-0.36), BIB: 92.15 (-2.11), PFE: 34.34 (+0.08), IBB: 373.58 (-4.00), DRGS: 60.10 (-0.69), LLY: 84.15 (-0.57), BMY: 64.30 (-1.68), GSK: 41.60 (+0.21), JNJ: 98.28 (-0.87), BIS: 27.60 (+0.54), AZN: 32.71 (-33.05), MRK: 56.99 (-0.42), ABBV: 69.34 (+1.26), SNY: 53.33 (-0.21), IRY: 53.60 (+0.02), IXJ: 110.30 (-0.45), NVS: 101.54 (-0.26)

ProShares planning a split for 21 ETFs
Seeking Alpha - at Seeking Alpha - Mon May 04, 11:51AM CDT

UYG: 77.15 (-1.27), SCC: 42.70 (unch), ROM: 77.25 (-1.77), UCO: 27.78 (-1.38), SAA: 57.09 (-0.84), RXL: 74.53 (-0.46), BIB: 92.15 (-2.11), SSO: 64.92 (-0.76), UVXY: 32.15 (+3.04), RWM: 59.74 (+0.52), UMDD: 58.24 (-1.43), DDM: 64.82 (-0.97), QLD: 77.17 (-1.35), UPRO: 66.91 (-1.22), YCL: 52.20 (unch), BOIL: 43.49 (+0.23), UCD: 40.25 (-0.25), RXD: 46.87 (unch), CSM: 49.87 (-0.38), UDOW: 66.14 (-1.59), SRS: 50.49 (-0.15)

ProShares Announces ETF Share Splits
Business Wire - Fri May 01, 3:05PM CDT
ProShares, a premier provider of alternative ETFs, announced today forward and reverse share splits on 21 of its ETFs. The splits will not change the value of a shareholder's investment.
ROM: 77.25 (-1.77), UCO: 27.78 (-1.38), BIB: 92.15 (-2.11)

Biotechs continue slide
Seeking Alpha - at Seeking Alpha - Wed Apr 29, 11:42AM CDT

BIS: 27.60 (+0.54), BIB: 92.15 (-2.11), IBB: 373.58 (-4.00)

Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound after Yesterday's 8.25% Sell Off
Comtex SmarTrend(R) - Mon Apr 27, 5:06PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $161.49 to a high of $178.64. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $175.31 on volume of 1.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 92.15 (-2.11)

Drug makers getting visability over aggressive pricing practices
Seeking Alpha - at Seeking Alpha - Mon Apr 27, 10:19AM CDT

MNK: 123.08 (-0.74), BIS: 27.60 (+0.54), VRX: 257.30 (+5.38), BIB: 92.15 (-2.11), IBB: 373.58 (-4.00), DRGS: 60.10 (-0.69)

U.S. drug spending rose 13% in 2014
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 6:28AM CDT

BIS: 27.60 (+0.54), BIB: 92.15 (-2.11), IBB: 373.58 (-4.00), DRGS: 60.10 (-0.69), IXJ: 110.30 (-0.45), IRY: 53.60 (+0.02)

BUYINS.NET: DFJ, PTH, UNL, TQQQ, KW, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Apr 10, 6:59AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of WisdomTree Japan Smallcap Dividend Fund (NYSEFJ), PowerShares Dynamic Heathcare Sector Portfolio (NYSETH), United States 12 Month Natural Gas Fund LP (NYSE:UNL), ProShares Trust UltraPro QQQ ETF (NASDAQ:TQQQ), Kennedy Wilson Holdings Inc (NYSE:KW), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BIB: 92.15 (-2.11), PTH: 63.95 (-0.36), KW: 25.25 (-0.09), DFJ: 55.53 (-0.57), UNL: 12.68 (+0.04), TQQQ: 114.93 (-3.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 2

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading
DIFF Eyewear Opens First Flagship Store in Charleston

Updated Category News Views 2

DIFF Eyewear: From Clicks to Bricks in Charleston Here's a tale of a brand shaking things up, jumping from the digital stratosphere right into solid ground. DIFF Eyewear has officially planted its flag in Charleston, SC, marking a bold transition from being an exclusively online player to real-world retail. October 10th rang in their first brick-and-mortar store on...

Continue Reading
2026 Leica Oskar Barnack Awards Spotlight Global Talent

Updated Category News Views 6

Winners Redefine Photography's Boundaries in 2026 Photographers are like modern-day storytellers, freezing moments in time and weaving visual narratives that provoke thought—or at least that's what the folks behind the Leica Oskar Barnack Award (LOBA) seem to believe. This year's ceremony upped the ante, not just handing out glittering prizes and shiny cameras, but...

Continue Reading
ODL’s Impact Door System Wins 2026 Editors' Pick

Updated Category News Views 3

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 0

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
Mastering Packaging Costs: Beyond the Box Price

Updated Category News Views 4

Peeling Back the Layers of Packaging Costs Packaging's a bit like an onion—every layer you peel back reveals another cost you didn’t see at first glance. Folks in the know, like Kyle Reger of Jamestown Container Companies, are flipping the script on how we approach packaging expenses. It's not just about snagging the cheapest box on the shelf anymore. There's a whole...

Continue Reading
Greenberg Traurig Nabs Major Award for Sukuk Deal

Updated Category News Views 3

Legal brands winning awards might seem like just another day in the office, but when a firm like Greenberg Traurig snags the Impact Deal of the Year at the IFLR Middle East Awards, it deserves more than just a shrug. We're talking about a serious feather in the cap for their Capital Markets team, who played a key role in launching Binghatti's hefty USD 1.5 billion Sukuk...

Continue Reading
Duke Energy Braces for Isaias: Key Prep Steps Ahead

Updated Category News Views 3

Brace Yourself: Duke Energy Gears Up for Isaias In the ever-unpredictable game of Mother Nature versus infrastructure, Duke Energy is stepping into the ring once more, readying to tackle potential outages across the Carolinas as Hurricane Isaias edges near. Listen, if there's one thing I've learned over years of watching these weather events unfold on the stock ticker and...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 3

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Bill Evans Enhances Gateway's Wealth Management Expertise

Updated Category News Views 3

Welcome Aboard, Bill Evans Some days the financial world throws a gem your way, something worth more than a rat-race racehorse in a shattered stock rally. Meet Bill Evans, a seasoned professional stepping into the vibrant arena of Gateway Financial Partners. He’s put in 29 years around the investment block, and now he’s parking himself in Glastonbury, Connecticut, set...

Continue Reading
g/news?page=2">More News Articles